Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
Tumor-Associated Trypsin Inhibitor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Background and Aim: Chronic pancreatitis and pancreatic ductal adenocarcinoma (PDA) frequently overexpress epidermal growth… Expand
Review
2011
Review
2011
Serine protease inhibitor Kazal type 1 (SPINK1) was originally identified as a trypsin inhibitor by Kazal et al. in 1948. SPINK1… Expand
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL
Colorectal cancer (CRC) is one of the most serious… Expand
2010
2010
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC
Serine protease inhibitor Kazal type 1 (SPINK1… Expand
2007
2007
After the discovery of estrogen receptor beta (ERβ) in 1995, it became clear that in many “non-classical” estrogen-responsive… Expand
2001
2001
Chromogranin A (CGA) is a low MW (49,000) acidic hydrophilic protein. It is synthesized in the chromaffm granules of the… Expand
1998
1998
TATI (tumor associated trypsin inhibitor) is a low molecular weight protein employed as a tumor marker. To evaluate the role of… Expand
1992
1992
189 clinical and serological examinations were performed in 30 patients before treatment and during follow up of squamous cell… Expand
1990
1990
CA 125, CA 50 and Tumor Associated Trypsin Inhibitor (TATI) levels were assayed in blood samples drawn at diagnosis from 149… Expand